Who are interleukin-1's main competitors?

Direct comparators (same drug class / molecular target / therapeutic area): Ilaris, Apokyn, Acid Reflux Relief, SODIUM PHOSPHATE, DIBASIC, SODIUM CARBONATE, Immune Support.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/interleukin-1.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-05-13 · How we verify

interleukin-1 — Competitive Intelligence Brief

interleukin-1 (interleukin-1) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Non-Standardized Plant Allergenic Extract [EPC].

marketed Non-Standardized Plant Allergenic Extract [EPC] Small molecule Live · refreshed every 30 min

Target snapshot

interleukin-1 (interleukin-1) — National Cancer Institute (NCI).

Comparator set (6 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
interleukin-1 TARGET	interleukin-1	National Cancer Institute (NCI)	marketed	Non-Standardized Plant Allergenic Extract [EPC]
Ilaris	CANAKINUMAB	Novartis Pharms	marketed	Non-Standardized Plant Allergenic Extract [EPC]	Interleukin-1 beta	2009-01-01
Apokyn	APOMORPHINE	Mdd Us	marketed	Non-Standardized Plant Allergenic Extract [EPC]	D(2) dopamine receptor	2004-01-01
Acid Reflux Relief	Sodium Phosphate, Dibasic, Heptahydrate	Pfizer	marketed	Non-Standardized Plant Allergenic Extract [EPC]	Carbonic anhydrase 4	1983-01-01
SODIUM PHOSPHATE, DIBASIC	SODIUM PHOSPHATE, DIBASIC		marketed	Non-Standardized Plant Allergenic Extract [EPC]		1983-01-01
SODIUM CARBONATE	SODIUM CARBONATE		marketed	Non-Standardized Plant Allergenic Extract [EPC]		1982-01-01
Immune Support	CORTISONE	Merck	marketed	Non-Standardized Plant Allergenic Extract [EPC]		1974-01-01

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

2028-06-22 — Acid Reflux Relief · 7687075 · US

Sponsor landscape (Non-Standardized Plant Allergenic Extract [EPC] class)

· 4 drugs in this class
BioNTech · 2 drugs in this class
Dey · 1 drug in this class
Fudan University · 1 drug in this class
Green Cross Corporation · 1 drug in this class
Mdd Us · 1 drug in this class
Merck · 1 drug in this class
National Cancer Institute (NCI) · 1 drug in this class
National Center for Complementary and Integrative Health (NCCIH) · 1 drug in this class
Novartis Pharmaceuticals · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). interleukin-1 — Competitive Intelligence Brief. https://druglandscape.com/ci/interleukin-1. Accessed 2026-05-13.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab